BXP · News · 20260805N

Occupancy and Leasing Activity

BXP, Inc. · 2026-08-05 · Importance 47 · Surprise 60 · In source text

BXP achieved significant leasing milestones during the second quarter of 2026. The leasing progress contributed to funds from operations exceeding guidance and supported an increased full-year FFO outlook. However, the reported leasing success is accompanied by increased leasing capital expenditures, which could weigh on future cash earnings. The digest does not identify specific tenants, lease volumes, rental rates, or geographic markets.

Key facts

Seres Therapeutics terminated its lease early for a facility at 200 Sidney St. in Cambridge. source
Seres Therapeutics had held the terminated lease at 200 Sidney St. for approximately a decade. source

Impact estimates

metric	direction	stage	expected	basis
revenue	negative	contingent	—	Seres Therapeutics terminated its lease early for a facility at 200 Sidney St. in Cambridge.